Cassidy Bio
PrivateLast Round
Seed
Nov 20, 2025
Total Funding Raised
$8M
Company Overview
Cassidy Bio is a biotechnology company developing an AI-driven genomic foundation model to enhance the design of gene editing therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cassidy Bio Comps
Public and private peers based on sector, stage, and business model.
Cassidy Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 20, 2025 |
Key People
Founding team and executive leadership
Cassidy Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lool Ventures | Seed |
| Merck KGaA | Seed |
| Ahren Innovation Capital | Seed |
Cassidy Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cassidy Bio's valuation, stock price, and market status.
